Development and characterization of a novel Cremophor® EL free liposome-based paclitaxel (LEP-ETU) formulation
- 1 January 2005
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 59 (1), 177-187
- https://doi.org/10.1016/j.ejpb.2004.06.009
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Real-time pharmacokinetics guiding clinical decisions: phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumoursEuropean Journal Of Cancer, 2004
- Long term stability of freeze-dried, lyoprotected doxorubicin liposomesEuropean Journal of Pharmaceutics and Biopharmaceutics, 1997
- Improvements in the preparation of liposomes for electron microscopy and electronspectroscopic imaging (ESI)Microscopy Research and Technique, 1994
- Liposomal Drug DeliveryClinical Pharmacokinetics, 1991
- Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injectionBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol componentsLife Sciences, 1982
- Liposome disposition in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1981
- Alkaline hydrolysis of phospholipids in model membranes and the dependence on their state of aggregationBiochemistry, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971